Vero cell-adapted SARS-CoV-2 strain shows increased viral growth through furin-mediated efficient spike cleavage

Shohei Minami,Tomohiro Kotaki,Yusuke Sakai,Shinya Okamura,Shiho Torii,Chikako Ono,Daisuke Motooka,Rina Hamajima,Ryotaro Nouda,Jeffery A. Nurdin,Moeko Yamasaki,Yuta Kanai,Hirotaka Ebina,Yusuke Maeda,Toru Okamoto,Taro Tachibana,Yoshiharu Matsuura,Takeshi Kobayashi
DOI: https://doi.org/10.1128/spectrum.02859-23
IF: 3.7
2024-02-28
Microbiology Spectrum
Abstract:ABSTRACT Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) utilizes several host proteases to cleave the spike (S) protein to enter host cells. SARS-CoV-2 S protein is cleaved into S1 and S2 subunits by furin, which is closely involved in the pathogenicity of SARS-CoV-2. However, the effects of the modulated protease cleavage activity due to S protein mutations on viral replication and pathogenesis remain unclear. Herein, we serially passaged two SARS-CoV-2 strains in Vero cells and characterized the cell-adapted SARS-CoV-2 strains in vitro and in vivo . The adapted strains showed high viral growth, effective S1/S2 cleavage of the S protein, and low pathogenicity compared with the wild-type strain. Furthermore, the viral growth and S1/S2 cleavage were enhanced by the combination of the Δ68–76 and H655Y mutations using recombinant SARS-CoV-2 strains generated by the circular polymerase extension reaction. The recombinant SARS-CoV-2 strain, which contained the mutation of the adapted strain, showed increased susceptibility to the furin inhibitor, suggesting that the adapted SARS-CoV-2 strain utilized furin more effectively than the wild-type strain. Pathogenicity was attenuated by infection with effectively cleaved recombinant SARS-CoV-2 strains, suggesting that the excessive cleavage of the S proteins decreases virulence. Finally, the high-growth-adapted SARS-CoV-2 strain could be used as the seed for a low-cost inactivated vaccine; immunization with this vaccine can effectively protect the host from SARS-CoV-2 variants. Our findings provide novel insights into the growth and pathogenicity of SARS-CoV-2 in the evolution of cell-cell transmission. IMPORTANCE The efficacy of the S protein cleavage generally differs among the SARS-CoV-2 variants, resulting in distinct viral characteristics. The relationship between a mutation and the entry of SARS-CoV-2 into host cells remains unclear. In this study, we analyzed the sequence of high-growth Vero cell-adapted SARS-CoV-2 and factors determining the enhancement of the growth of the adapted virus and confirmed the characteristics of the adapted strain by analyzing the recombinant SARS-CoV-2 strain. We successfully identified mutations Δ68-76 and H655Y, which enhance viral growth and the S protein cleavage by furin. Using recombinant viruses enabled us to conduct a virus challenge experiment in vivo . The pathogenicity of SARS-CoV-2 introduced with the mutations Δ68-76, H655Y, P812L, and Q853L was attenuated in hamsters, indicating the possibility of the attenuation of excessive cleaved SARS-CoV-2. These findings provide novel insights into the infectivity and pathogenesis of SARS-CoV-2 strains, thereby significantly contributing to the field of virology.
microbiology
What problem does this paper attempt to address?
The problems that this paper attempts to solve mainly focus on the following aspects: 1. **Explore the impact of adaptive mutations of SARS - CoV - 2 in Vero cells on virus replication and pathogenicity**: Through continuous passage experiments, the researchers obtained adaptive mutants of two SARS - CoV - 2 strains (Kng and B - 1) in Vero cells and analyzed the growth characteristics of these mutants, the cleavage efficiency of the spike protein (S protein), and the changes in their pathogenicity. 2. **Determine the impact of specific mutations on S - protein cleavage and virus growth**: Special attention was paid to two key mutations - Δ68–76 and H655Y, to study how they enhance the cleavage efficiency of the S - protein and, in turn, affect the virus growth rate. The researchers used recombinant SARS - CoV - 2 viruses to conduct a series of experiments to verify the functions of these mutations. 3. **Evaluate the changes in pathogenicity of adaptive mutants**: Through mouse model experiments, the researchers compared the body weight loss, lung inflammation, and other indicators of wild - type SARS - CoV - 2 and adaptive mutants after infecting animals, and found that the pathogenicity of adaptive mutants was significantly reduced. 4. **Explore the relationship between S - protein cleavage and virus growth**: Through inhibitor experiments and deletion mutation experiments, the researchers confirmed the important role of furin - mediated S - protein cleavage in virus growth. Specifically, the Δ68–76 and H655Y mutations promoted the growth of the virus in Vero cells by enhancing furin - mediated S - protein cleavage. 5. **Explore the possibility of adaptive mutants as vaccine seeds**: The researchers pointed out that high - growth - rate adaptive mutants can be used as seeds for low - cost inactivated vaccines for immunization, effectively protecting the host from infection by SARS - CoV - 2 variants. In summary, this paper aims to reveal the mechanism of adaptive mutations of SARS - CoV - 2 in Vero cells and their impact on the biological characteristics and pathogenicity of the virus through detailed experiments and analysis, providing new insights for virology research and vaccine development.